Balint, E., Szabo, P., Marshall, C.F., Sprague, S.M.: Glucose induced inhibition of in vitro bone mineralization. Bone, 28:21-28, 2001. Balint, E., Sprague, S.M.: 2-Microglobulin and bone cell metabolism, Nephrology Dialysis Transplantation, 16:1108-1111, 2001. Sprague, S.M., Llach, F., Amdahl, M., Taccetta, C., Batlle, D.: Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney International 63:1483-1490, 2003. Cunningham, J., Sprague, S.M.: Controversies in Bone and Mineral Metabolism:Osteoporosis in Chronic Kidney Disease. American Journal of Kidney Diseases, 43:566-571, 2004. Dobrez, D.G., Mathes, A., Amdahl, M., Marx, S.E.,. Melnick, J.Z., Sprague, S.M.: Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Nephrology Dialysis Transplantation, 19:1174-1181, 2004. Josephson, M.A., Schumm, L.P., Chiu, M.Y., Marshall, C., Thistlethwaite, J.R., Sprague, S.M.: Calcium and calcitriol prophylaxis attenuates post-transplant bone loss. Transplantation 78:1233-1236, 2004. Daniels, C.M., Wolverton, E., Sprague, S.M., Ameer, G.A.: Assessment of the stability of an immunoadsorbent for the extracorporeal removal of 2-microglobulin from blood. Blood Purification 23:287-297, 2005. Moe, S.M., Cunningham, J., Bommer, J., Adler, S., Rosansky, S.J., Urena-Torres, P., Albizem, M.B., Guo, M.D., Zani, V.J., Goodman, W.G., Sprague, S.M.: Long-term Treatment of Secondary Hyperparathyroidism with the Calcimimetic Cinacalcet HCl. Nephrology Dialysis Transplantation 10:2186-93, 2005. Zisman, A.L., Ghantous, W., Schinleber, P., Roberts, L., Sprague, S.M.: Inhibition of Parathyroid Hormone: A Dose Equivalency Study of Paricalcitol and Doxercalciferol. American Journal of Nephrology 25:591-595, 2005. |
